GL1X · GenesisL1 explorer

MolNFT v1 · #165858 · protein

Discovery and optimization of salicyclic acid-derived sulfonamide inhibitors of the WDR5:MYC protein-protein interaction

6U8L · Wd repeat-containing protein 5: “Discovery and optimization of salicyclic acid-derived sulfonamide inhibitors of the WDR5:MYC protein-protein…”. X-ray diffraction, 2 ligands (Q1P, Q1S), 4 pockets (best druggability 0.76). MolNFT v1…

PDB
6U8L
Type
protein
Length
608 residues
Chains
2
Method
x-ray diffraction
Collection
MolNFT v1 / PDB
Contract
0xDE3723766Bc32dcACD03C17BaA400A7B36837Eba
Owner
0x3396CDB397284571d12822B4ae1189a8E22AAAAA
Molecule
Wd repeat-containing protein 5
UniProt
P61964
Ligands
Q1P, Q1S
Pockets
4 · best druggability 0.76

Structure

x-ray diffraction · 1 distinct chain · 0% helix, 52% strand (DSSP).

ChainMoleculeTypeResiduesSecondary structureUniProt
A, BWd repeat-containing protein 5protein3040% helix, 52% strandP61964

Ligands and binding sites

  • Q1P · 3-{[(5-bromo-2-hydroxyphenyl)sulfonyl]amino}-5-cyclopropyl-6-fluoro-2-hydroxybenzoic acid · ligand · 2 copies · chains A, B
  • Q1S · N-[2-(4-methylpiperazin-1-yl)-5-nitrophenyl]isoquinolin-1-amine · ligand · 2 copies · chains A, B

Binding sites are the residues within 4.5 Å of a ligand's heavy atoms.

Pockets

4 pockets found on a 1 Å grid, 3 with a druggability of 0.5 or more.

PocketVolume (ų)DruggabilityBuriednessLining residuesInside
17260.760.8165Q1S
24560.710.8134empty
32550.630.8136Q1S
4500.310.7615Q1P

Compared structures

  • 6U8L · Discovery and optimization of salicyclic acid-derived sulfonamide inhibitors of the… · the same entry in another collection · chain A against A, TM-score 1.00

Analyse

GL1X is a live explorer of the GenesisL1 blockchain. Turn on JavaScript for search, charts and interactive views.